Publication | Open Access
Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?
46
Citations
32
References
2017
Year
Metabolic SyndromeCardiovascular DiseaseNovel MarkerMedicineDiabetesType 2Plasma CeramidePharmacotherapyDiabetes MellitusPharmacologyAtherosclerosisDyslipidemia
| Year | Citations | |
|---|---|---|
Page 1
Page 1